{"mainPropery":{"diseaseId":4503,"diseaseName":"Chronic progressive external ophthalmoplegia","hasGardWebPage":true,"isRare":true,"websiteUrl":"https://rarediseases.info.nih.gov/diseases/4503/chronic-progressive-external-ophthalmoplegia","synonyms":["Progressive external ophthalmoplegia","CPEO"],"synonyms-with-source":[{"name":"Progressive external ophthalmoplegia"},{"name":"CPEO"}],"identifiers":[{"identifierType":"UMLS","identifierId":"C0162674"}]},"diseaseCategories":[{"diseaseTypeId":5,"diseaseTypeName":"Congenital and Genetic Diseases"},{"diseaseTypeId":9,"diseaseTypeName":"Eye diseases"},{"diseaseTypeId":14,"diseaseTypeName":"Metabolic disorders"},{"diseaseTypeId":17,"diseaseTypeName":"Nervous System Diseases"}],"organizations":[{"resourceID":176,"resourceName":"United Mitochondrial Disease Foundation","abbreviation":"","address1":"8085 Saltsburg Road, Suite 201","address2":"","address3":"","address4":"","address5":"","city":"Pittsburgh","state":"PA","zip":"15239 ","country":"United States","phone":"+1-412-793-8077 ","tty":"","tollFree":"1-888-317-8633","fax":"+1-412-793-6477 ","email":"info@umdf.org","url":"https://www.umdf.org","freeText":""},{"resourceID":204,"resourceName":"The Mitochondria Research and Medicine Society","abbreviation":"","address1":"PO Box 55322","address2":"","address3":"","address4":"","address5":"","city":"Birmingham","state":"AL","zip":"","country":"","phone":"716-907-4349 ","tty":"","tollFree":"","fax":"716-845-1047 ","email":"contact@mitoresearch.org ","url":"http://www.mitoresearch.org","freeText":""}],"resource descriptions":[{"id":8,"resourceId":11,"resourceName":"PubMed","descriptionText":"<a href='http://www.ncbi.nlm.nih.gov/pubmed?term=CPEO%5Bti%5D%20OR%20chronic%20progressive%20external%20ophthalmoplegia%5Bti%5D&cmd=DetailsSearch' target='_blank'>PubMed</a> is a searchable database of medical literature and lists journal articles that discuss Chronic progressive external ophthalmoplegia. Click on the link to view a sample search on this topic.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":10,"resourceId":13,"resourceName":"MedlinePlus Genetics","descriptionText":"<a href='http://ghr.nlm.nih.gov/condition/progressive-external-ophthalmoplegia' target='_blank'>Genetics Home Reference (GHR)</a> contains information on Chronic progressive external ophthalmoplegia. This website is maintained by the National Library of Medicine.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":776,"resourceId":1461,"resourceName":"GeneReview - Mitochondria general","descriptionText":"<a href='http://www.ncbi.nlm.nih.gov/bookshelf/br.fcgi?book=gene&amp;part=mt-overview ' target='_blank'>GeneReviews</a> provides a current, expert-authored, peer-reviewed, full-text article on mitochondrial disorders, including CPEO. GeneReview articles describe the application of genetic testing to the diagnosis, management, and genetic counseling of patients with specific inherited conditions. ","resourceClassificationName":"Treatment","resourceClassificationSectionName":"Management Guidelines"},{"id":874,"resourceId":1580,"resourceName":"RDCRN - North American Mitochondrial Disease Consortium (NAMDC)","descriptionText":"The&nbsp;<a href='https://www.rarediseasesnetwork.org/cms/namdc' target='_blank'>North American Mitochondrial Disease Consortium (NAMDC)</a> is a team of doctors, nurses, research coordinators, and research labs throughout the U.S., working together to improve the lives of people with this condition through research.","resourceClassificationName":"Research","resourceClassificationSectionName":"Clinical Research Resources"},{"id":1264,"resourceId":176,"resourceName":"United Mitochondrial Disease Foundation","descriptionText":"You can submit a question to <a href='http://pi.umdf.org/l/346741/2017-11-01/7vxq' target='_blank'>Ask the Mito Doc</a>, a service of the United Mitochondrial Diseases Foundation. Information contained in Ask the Mito Doc<small><sup>SM</sup></small> is for informational and educational purposes only.","resourceClassificationName":"Find a Specialist","resourceClassificationSectionName":"Healthcare Resources"},{"id":1400,"resourceId":12,"resourceName":"ClinicalTrials.gov","descriptionText":"The U.S. National Institutes of Health, through the National Library of Medicine, developed ClinicalTrials.gov to provide patients, family members, and members of the public with current information on clinical research studies. There is a study titled&nbsp;<a href='http://clinicaltrials.gov/ct2/show/NCT00655096?term=for+NEI+Clinical+Studies&amp;rank=3  ' target='_blank'>Screening Study for the Evaluation and Diagnosis of Potential Research Participants</a><strong> </strong>which may be of interest to you.","resourceClassificationName":"Research","resourceClassificationSectionName":"Clinical Research Resources"},{"id":1531,"resourceId":2162,"resourceName":"Medscape Reference","descriptionText":"<a href='http://emedicine.medscape.com/article/1215103-overview' target='_blank'>Medscape Reference</a> provides information on this topic. You may need to register to view the medical textbook, but registration is free.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":1542,"resourceId":2170,"resourceName":"RePORTER","descriptionText":"The <a href='http://projectreporter.nih.gov/reporter.cfm' target='_blank'>Research Portfolio Online Reporting Tool (RePORT)</a> provides access to reports, data, and analyses of research activities at the National Institutes of Health (NIH), including information on NIH expenditures and the results of NIH-supported research.  Although these projects may not conduct studies on humans, you may want to contact the investigators to learn more. To search for studies, enter the disease name in the \"Text Search\" box.  Then click \"Submit Query\".","resourceClassificationName":"Research","resourceClassificationSectionName":"Clinical Research Resources"},{"id":2021,"resourceId":10,"resourceName":"Online Mendelian Inheritance in Man (OMIM)","descriptionText":"<a href='http://omim.org/phenotypicSeries/PS157640' target='_blank'>Online Mendelian Inheritance in Man (OMIM)</a> lists the subtypes and associated genes for Chronic progressive external ophthalmoplegia in a table called Phenotypic Series. Each entry in OMIM includes a summary of related medical articles. It is meant for health care professionals and researchers. OMIM is maintained by Johns Hopkins University School of Medicine.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":2135,"resourceId":3342,"resourceName":"Monarch Initiative","descriptionText":"The <a href='https://monarchinitiative.org/disease/DOID:12558' target='_blank'>Monarch Initiative</a> brings together data about this condition from humans and other species to help physicians and biomedical researchers. Monarch&rsquo;s tools are designed to make it easier to compare the signs and symptoms (phenotypes) of different diseases and discover common features. This initiative is a collaboration between several academic institutions across the world and is funded by the National Institutes of Health. Visit the website to explore the biology of this condition.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"}],"overviewQuestion":{"questionId":2771,"questionText":"What is chronic progressive external ophthalmoplegia?","answerText":"<strong>Chronic progressive external ophthalmoplegia</strong> (CPEO) is a condition characterized mainly by a loss of the muscle functions involved in eye and eyelid movement. Signs and symptoms tend to begin in early adulthood and most commonly include weakness or paralysis of the muscles that move the eye (ophthalmoplegia) and drooping of the eyelids (ptosis).[1802][6261] Some affected individuals also have general weakness of the skeletal muscles (myopathy), which may be especially noticeable during exercise. Muscle weakness may also cause difficulty swallowing (dysphagia). CPEO can be caused by <a href=\"http://www.genome.gov/glossary/index.cfm?id=134\" target=\"_blank\">mutations</a> in any of several <a href=\"http://www.genome.gov/glossary/index.cfm?id=70\" target=\"_blank\">genes</a>, which may be located in <a href=\"http://ghr.nlm.nih.gov/handbook/basics/mtdna\" target=\"_blank\">mitochondrial DNA</a> or <a href=\"http://ghr.nlm.nih.gov/handbook/basics/dna\" target=\"_blank\">nuclear DNA</a>. It has different inheritance patterns depending on the gene involved in the affected individual.[6261]<br />\r\n<br />\r\nCPEO can occur as part of other underlying conditions, such as <a href=\"http://ghr.nlm.nih.gov/condition/ataxia-neuropathy-spectrum\" target=\"_blank\">ataxia neuropathy spectrum</a> and <a href=\"http://rarediseases.info.nih.gov/gard/6817/kearns-sayre-syndrome/Resources/1\" target=\"_blank\">Kearns-Sayre syndrome</a>. These conditions&nbsp;may not only involve CPEO, but various additional features that are not shared by most individuals with CPEO.[6261]<br />","dateModified":"2017-01-19T00:00:00"},"basicQuestions":[{"questionId":2773,"questionText":"What are the signs and symptoms of chronic progressive external ophthalmoplegia?","answerText":"The signs and symptoms of chronic progressive external ophthalmoplegia (CPEO) typically begin in young adults between the ages of 18 and 40.[1802][6261] The most common symptoms in affected individuals include drooping eyelids (ptosis) and weakness or paralysis of the eye muscles (ophthalmoplegia). The condition may be unilateral (affecting one eye) or bilateral (affecting both eyes).[1803] Some affected individuals also have weakness of the skeletal muscles (myopathy), specifically of the arms, legs, and/or neck. This may be especially noticeable during exercise.[1802][6261] Muscle weakness may also cause difficulty swallowing (dysphagia).[6261]<br />\r\n<br />\r\nSometimes, CPEO may be associated with other signs and symptoms. In these cases, the condition is referred to as \"progressive external ophthalmoplegia plus\" (PEO+). Additional signs and symptoms can include hearing loss caused by nerve damage in the inner ear (sensorineural hearing loss), weakness and loss of sensation in the limbs due to nerve damage (neuropathy), impaired muscle coordination (ataxia), a pattern of movement abnormalities known as parkinsonism, or depression.[6261]<br />\r\n<br />","dateModified":"2017-01-19T00:00:00","resourceClassificationName":"Symptoms","references":[{"referenceId":1802,"authors":"DiMauro S, Michio H","articleTitle":"Mitochondrial DNA Deletion Syndromes","bookWebsiteJournalTitle":"GeneReviews","date":"May 3, 2011","volume":"","pages":"","url":"https://www.ncbi.nlm.nih.gov/books/NBK1203/","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":1803,"authors":"Van Goethem, Gert et al. ","articleTitle":"Progressive External Ophthalmoplegia Characterized by Multiple Deletions of Mitochondrial DNA","bookWebsiteJournalTitle":"NeuroMolecular Medicine ","date":"2003"},{"referenceId":6261,"authors":"","articleTitle":"Progressive external ophthalmoplegia","bookWebsiteJournalTitle":"Genetics Home Reference","date":"May 2016","volume":"","pages":"","url":"http://ghr.nlm.nih.gov/condition/progressive-external-ophthalmoplegia","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":2772,"questionText":"Is&nbsp;chronic progressive external ophthalmoplegia inherited?","answerText":"Chronic progressive external ophthalmoplegia (CPEO) can be inherited, or it can occur sporadically (due to a new mutation in an individual with no history of the condition in the family).<br />\r\n<br />\r\nCPEO is considered a \"mitochondrial disorder.\" This is because all the genetic mutations that can cause CPEO ultimately result in dysfunction of the mitochondria, which are structures in our cells that produce energy required for normal cell function. While most of our DNA is located in the cell's center (<a href=\"http://ghr.nlm.nih.gov/handbook/basics/dna\" target=\"_blank\">nuclear DNA</a>), some of our DNA is located within the mitochondria (<a href=\"http://ghr.nlm.nih.gov/handbook/basics/mtdna\" target=\"_blank\">mitochondrial DNA</a>).[1802] CPEO can be caused by mutations in any of several genes, which may be located in mitochondrial DNA or nuclear DNA. It has different inheritance patterns depending on the gene involved in the affected individual.[6261]<br />\r\n<br />\r\nUnlike nuclear DNA which is inherited from both the mother and the father, mitochondrial DNA is inherited from only the mother. In CPEO, the affected mitochondria (i.e., the ones carrying the mutations) are found only in the skeletal muscle cells. These mitochondrial DNA mutations are almost always sporadic (occurring by chance for the first time in the affected individual). Nuclear gene mutations that cause CPEO may be inherited in an <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/002052.htm\" target=\"_blank\">autosomal recessive</a> or <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/002049.htm\" target=\"_blank\">autosomal dominant</a> manner, depending on the gene involved.[1802] The risk for other family members to be affected depends on the genetic cause and the inheritance pattern in the family.","dateModified":"2017-01-19T00:00:00","resourceClassificationName":"Inheritance","references":[{"referenceId":1802,"authors":"DiMauro S, Michio H","articleTitle":"Mitochondrial DNA Deletion Syndromes","bookWebsiteJournalTitle":"GeneReviews","date":"May 3, 2011","volume":"","pages":"","url":"https://www.ncbi.nlm.nih.gov/books/NBK1203/","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":6261,"authors":"","articleTitle":"Progressive external ophthalmoplegia","bookWebsiteJournalTitle":"Genetics Home Reference","date":"May 2016","volume":"","pages":"","url":"http://ghr.nlm.nih.gov/condition/progressive-external-ophthalmoplegia","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":2776,"questionText":"How might chronic progressive external ophthalmoplegia be treated?","answerText":"Ptosis caused by&nbsp;chronic progressive external ophthalmoplegia (CPEO)&nbsp;can be corrected by surgery, or by using glasses that have a &ldquo;ptosis crutch&rdquo; to lift the upper eyelids.[1805] <a href=\"http://www.strabismus.org/surgery_crossed_eyes.html\" target=\"_blank\">Strabismus surgery</a> can be helpful in carefully selected patients if diplopia (double vision) occurs.[1804] <br />\r\n<br />\r\nSome individuals with&nbsp;a&nbsp;deficiency of coenzyme Q10 have CPEO as an associated abnormality. Coenzyme Q10 is important for&nbsp;normal mitochondrial function. In individuals with this deficiency, supplemental coenzyme Q10 has been found to improve general neurologic function and exercise tolerance.&nbsp;However, coenzyme Q10 has not been shown to&nbsp;improve the ophthalmoplegia or ptosis in&nbsp;people who have isolated CPEO.[1802]","dateModified":"2017-01-19T00:00:00","resourceClassificationName":"Treatment","references":[{"referenceId":1802,"authors":"DiMauro S, Michio H","articleTitle":"Mitochondrial DNA Deletion Syndromes","bookWebsiteJournalTitle":"GeneReviews","date":"May 3, 2011","volume":"","pages":"","url":"https://www.ncbi.nlm.nih.gov/books/NBK1203/","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":1804,"authors":"Mercandetti M, Cohen AJ","articleTitle":"Chronic Progressive External Ophthalmoplegia","bookWebsiteJournalTitle":"Medscape","date":"June 20, 2016","volume":"","pages":"","url":"http://emedicine.medscape.com/article/1215103-overview","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":1805,"authors":"","articleTitle":"Mitochondrial Myopathies (MM) Medical Management","bookWebsiteJournalTitle":"Muscular Dystrophy Association","date":"","volume":"","pages":"","url":"https://www.mda.org/disease/mitochondrial-myopathies/medical-management","dateAccessed":"2017-01-19T00:00:00","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":2777,"questionText":"What is the long-term outlook (prognosis) for individuals with chronic progressive external ophthalmoplegia?","answerText":"Chronic progressive external ophthalmoplegia (CPEO) can be an isolated condition, or it can occur as part of other underlying conditions, such as <a href=\"http://ghr.nlm.nih.gov/condition/ataxia-neuropathy-spectrum\" target=\"_blank\">ataxia neuropathy spectrum</a> and <a href=\"http://rarediseases.info.nih.gov/gard/6817/kearns-sayre-syndrome/Resources/1\" target=\"_blank\">Kearns-Sayre syndrome</a>. These conditions may involve not only CPEO, but various additional features that are not shared by most individuals with CPEO in isolation.[6261] Individuals with isolated CPEO generally have a normal life expectancy. While symptoms tend to worsen over time, the specific symptoms and their severity can vary greatly from person to person. Therefore, when symptoms first appear, the course of the condition is very difficult to predict.[1802][1806]<br />\r\n<br />\r\nFor individuals with additional symptoms or another underlying condition associated with CPEO, the prognosis depends on the specific signs and symptoms present and/or the outlook associated with the underlying condition in the affected individual. For this reason, obtaining an accurate diagnosis is very important.","dateModified":"2017-01-19T00:00:00","resourceClassificationName":"Prognosis","references":[{"referenceId":1802,"authors":"DiMauro S, Michio H","articleTitle":"Mitochondrial DNA Deletion Syndromes","bookWebsiteJournalTitle":"GeneReviews","date":"May 3, 2011","volume":"","pages":"","url":"https://www.ncbi.nlm.nih.gov/books/NBK1203/","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":1806,"authors":"Auré K, Ogier de Baulny H, Laforet P, Jardel C, Eymard B, Lombes A","articleTitle":"Chronic progressive ophthalmoplegia with large-scale mtDNA rearrangement: can we predict progression?","bookWebsiteJournalTitle":"Brain","date":"April 17, 2007","volume":"130(6)","pages":"1516-1524","url":"http://brain.oxfordjournals.org/cgi/content/full/130/6/1516?ck=nck","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":6261,"authors":"","articleTitle":"Progressive external ophthalmoplegia","bookWebsiteJournalTitle":"Genetics Home Reference","date":"May 2016","volume":"","pages":"","url":"http://ghr.nlm.nih.gov/condition/progressive-external-ophthalmoplegia","authors2":"","placeOfPublication":"","publisher":""}]}],"references":[],"relatedDiseases":[{"relatedDiseaseId":13053,"relatedDiseaseName":"Mitochondrial DNA Deletion Syndromes","relation":"Parent","isRare":true,"hasGardPage":false}],"gardCases":[{"caseId":41693,"abbreviatedInquiry":"Is chronic progressive external ophthalmoplegia fatal? If so, what is the life expectancy?","caseQuestions":[{"questionId":2777,"questionText":"What is the long-term outlook (prognosis) for individuals with chronic progressive external ophthalmoplegia?","answerText":"Chronic progressive external ophthalmoplegia (CPEO) can be an isolated condition, or it can occur as part of other underlying conditions, such as <a href=\"http://ghr.nlm.nih.gov/condition/ataxia-neuropathy-spectrum\" target=\"_blank\">ataxia neuropathy spectrum</a> and <a href=\"http://rarediseases.info.nih.gov/gard/6817/kearns-sayre-syndrome/Resources/1\" target=\"_blank\">Kearns-Sayre syndrome</a>. These conditions may involve not only CPEO, but various additional features that are not shared by most individuals with CPEO in isolation.[6261] Individuals with isolated CPEO generally have a normal life expectancy. While symptoms tend to worsen over time, the specific symptoms and their severity can vary greatly from person to person. Therefore, when symptoms first appear, the course of the condition is very difficult to predict.[1802][1806]<br />\r\n<br />\r\nFor individuals with additional symptoms or another underlying condition associated with CPEO, the prognosis depends on the specific signs and symptoms present and/or the outlook associated with the underlying condition in the affected individual. For this reason, obtaining an accurate diagnosis is very important.","dateModified":"2017-01-19T00:00:00","resourceClassificationName":"Prognosis","references":[{"referenceId":1802,"authors":"DiMauro S, Michio H","articleTitle":"Mitochondrial DNA Deletion Syndromes","bookWebsiteJournalTitle":"GeneReviews","date":"May 3, 2011","volume":"","pages":"","url":"https://www.ncbi.nlm.nih.gov/books/NBK1203/","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":1806,"authors":"Auré K, Ogier de Baulny H, Laforet P, Jardel C, Eymard B, Lombes A","articleTitle":"Chronic progressive ophthalmoplegia with large-scale mtDNA rearrangement: can we predict progression?","bookWebsiteJournalTitle":"Brain","date":"April 17, 2007","volume":"130(6)","pages":"1516-1524","url":"http://brain.oxfordjournals.org/cgi/content/full/130/6/1516?ck=nck","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":6261,"authors":"","articleTitle":"Progressive external ophthalmoplegia","bookWebsiteJournalTitle":"Genetics Home Reference","date":"May 2016","volume":"","pages":"","url":"http://ghr.nlm.nih.gov/condition/progressive-external-ophthalmoplegia","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":2773,"questionText":"What are the signs and symptoms of chronic progressive external ophthalmoplegia?","answerText":"The signs and symptoms of chronic progressive external ophthalmoplegia (CPEO) typically begin in young adults between the ages of 18 and 40.[1802][6261] The most common symptoms in affected individuals include drooping eyelids (ptosis) and weakness or paralysis of the eye muscles (ophthalmoplegia). The condition may be unilateral (affecting one eye) or bilateral (affecting both eyes).[1803] Some affected individuals also have weakness of the skeletal muscles (myopathy), specifically of the arms, legs, and/or neck. This may be especially noticeable during exercise.[1802][6261] Muscle weakness may also cause difficulty swallowing (dysphagia).[6261]<br />\r\n<br />\r\nSometimes, CPEO may be associated with other signs and symptoms. In these cases, the condition is referred to as \"progressive external ophthalmoplegia plus\" (PEO+). Additional signs and symptoms can include hearing loss caused by nerve damage in the inner ear (sensorineural hearing loss), weakness and loss of sensation in the limbs due to nerve damage (neuropathy), impaired muscle coordination (ataxia), a pattern of movement abnormalities known as parkinsonism, or depression.[6261]<br />\r\n<br />","dateModified":"2017-01-19T00:00:00","resourceClassificationName":"Symptoms","references":[{"referenceId":1802,"authors":"DiMauro S, Michio H","articleTitle":"Mitochondrial DNA Deletion Syndromes","bookWebsiteJournalTitle":"GeneReviews","date":"May 3, 2011","volume":"","pages":"","url":"https://www.ncbi.nlm.nih.gov/books/NBK1203/","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":1803,"authors":"Van Goethem, Gert et al. ","articleTitle":"Progressive External Ophthalmoplegia Characterized by Multiple Deletions of Mitochondrial DNA","bookWebsiteJournalTitle":"NeuroMolecular Medicine ","date":"2003"},{"referenceId":6261,"authors":"","articleTitle":"Progressive external ophthalmoplegia","bookWebsiteJournalTitle":"Genetics Home Reference","date":"May 2016","volume":"","pages":"","url":"http://ghr.nlm.nih.gov/condition/progressive-external-ophthalmoplegia","authors2":"","placeOfPublication":"","publisher":""}]}]},{"caseId":25068,"abbreviatedInquiry":"I would like to learn more about chronic progressive external opthalmoplegia, particularly how it can be treated. Also does the rate of progression vary from person to person? What is the typical prognosis (long term outlook) for people with this condition?&nbsp;Can chronic progressive external opthalmoplegia affect facial muscles as well?","caseQuestions":[{"questionId":2774,"questionText":"Is facial weakness a symptom of chronic progressive external ophthalmoplegia?","answerText":"Mitochondrial myopathies in general can cause weakness in muscles of the face and neck.[1805] In our search of the medical literature we were able to find case&nbsp;reports describing this symptom in&nbsp;people with&nbsp;chronic progressive external ophthalmoplegia specifically.","dateModified":"2017-01-19T00:00:00","references":[{"referenceId":1805,"authors":"","articleTitle":"Mitochondrial Myopathies (MM) Medical Management","bookWebsiteJournalTitle":"Muscular Dystrophy Association","date":"","volume":"","pages":"","url":"https://www.mda.org/disease/mitochondrial-myopathies/medical-management","dateAccessed":"2017-01-19T00:00:00","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":2775,"questionText":"Is chronic progressive external ophthalmoplegia found in any other conditions?","answerText":"Chronic progressive external ophthalmoplegia (CPEO) can be found&nbsp;in other forms of mitochondrial myopathies. In particular,&nbsp;CPEO is found in a related mitochondrial myopathy called <a href=\"https://rarediseases.info.nih.gov/diseases/6817/kearns-sayre-syndrome\" target=\"_blank\">Kearns-Sayre Syndrome</a>.&nbsp;<span style=\"font-size: 12pt;\">In addition, some people with&nbsp;CPEO have some symptoms of Kearns-Sayre syndrome, such as ataxia, dementia,</span><sup> </sup><span style=\"font-size: 12pt;\">or sensorineural hearing loss, in addition to the characteristic symptoms of CPEO.&nbsp;In these cases the people may&nbsp;be said to have&nbsp;CPEO-plus.[1802][6261]</span>\r\n<p>CPEO may also be found in other disorder such as&nbsp;<a href=\"https://rarediseases.info.nih.gov/diseases/7245/oculopharyngeal-muscular-dystrophy\" target=\"_blank\">oculopharyngeal muscular dystrophy</a>, and&nbsp;<a href=\"https://rarediseases.info.nih.gov/diseases/7122/myasthenia-gravis\" target=\"_blank\">myasthenia gravis</a>.[1802]&nbsp;</p>","dateModified":"2017-01-19T00:00:00","references":[{"referenceId":1802,"authors":"DiMauro S, Michio H","articleTitle":"Mitochondrial DNA Deletion Syndromes","bookWebsiteJournalTitle":"GeneReviews","date":"May 3, 2011","volume":"","pages":"","url":"https://www.ncbi.nlm.nih.gov/books/NBK1203/","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":6261,"authors":"","articleTitle":"Progressive external ophthalmoplegia","bookWebsiteJournalTitle":"Genetics Home Reference","date":"May 2016","volume":"","pages":"","url":"http://ghr.nlm.nih.gov/condition/progressive-external-ophthalmoplegia","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":2776,"questionText":"How might chronic progressive external ophthalmoplegia be treated?","answerText":"Ptosis caused by&nbsp;chronic progressive external ophthalmoplegia (CPEO)&nbsp;can be corrected by surgery, or by using glasses that have a &ldquo;ptosis crutch&rdquo; to lift the upper eyelids.[1805] <a href=\"http://www.strabismus.org/surgery_crossed_eyes.html\" target=\"_blank\">Strabismus surgery</a> can be helpful in carefully selected patients if diplopia (double vision) occurs.[1804] <br />\r\n<br />\r\nSome individuals with&nbsp;a&nbsp;deficiency of coenzyme Q10 have CPEO as an associated abnormality. Coenzyme Q10 is important for&nbsp;normal mitochondrial function. In individuals with this deficiency, supplemental coenzyme Q10 has been found to improve general neurologic function and exercise tolerance.&nbsp;However, coenzyme Q10 has not been shown to&nbsp;improve the ophthalmoplegia or ptosis in&nbsp;people who have isolated CPEO.[1802]","dateModified":"2017-01-19T00:00:00","resourceClassificationName":"Treatment","references":[{"referenceId":1802,"authors":"DiMauro S, Michio H","articleTitle":"Mitochondrial DNA Deletion Syndromes","bookWebsiteJournalTitle":"GeneReviews","date":"May 3, 2011","volume":"","pages":"","url":"https://www.ncbi.nlm.nih.gov/books/NBK1203/","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":1804,"authors":"Mercandetti M, Cohen AJ","articleTitle":"Chronic Progressive External Ophthalmoplegia","bookWebsiteJournalTitle":"Medscape","date":"June 20, 2016","volume":"","pages":"","url":"http://emedicine.medscape.com/article/1215103-overview","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":1805,"authors":"","articleTitle":"Mitochondrial Myopathies (MM) Medical Management","bookWebsiteJournalTitle":"Muscular Dystrophy Association","date":"","volume":"","pages":"","url":"https://www.mda.org/disease/mitochondrial-myopathies/medical-management","dateAccessed":"2017-01-19T00:00:00","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":2777,"questionText":"What is the long-term outlook (prognosis) for individuals with chronic progressive external ophthalmoplegia?","answerText":"Chronic progressive external ophthalmoplegia (CPEO) can be an isolated condition, or it can occur as part of other underlying conditions, such as <a href=\"http://ghr.nlm.nih.gov/condition/ataxia-neuropathy-spectrum\" target=\"_blank\">ataxia neuropathy spectrum</a> and <a href=\"http://rarediseases.info.nih.gov/gard/6817/kearns-sayre-syndrome/Resources/1\" target=\"_blank\">Kearns-Sayre syndrome</a>. These conditions may involve not only CPEO, but various additional features that are not shared by most individuals with CPEO in isolation.[6261] Individuals with isolated CPEO generally have a normal life expectancy. While symptoms tend to worsen over time, the specific symptoms and their severity can vary greatly from person to person. Therefore, when symptoms first appear, the course of the condition is very difficult to predict.[1802][1806]<br />\r\n<br />\r\nFor individuals with additional symptoms or another underlying condition associated with CPEO, the prognosis depends on the specific signs and symptoms present and/or the outlook associated with the underlying condition in the affected individual. For this reason, obtaining an accurate diagnosis is very important.","dateModified":"2017-01-19T00:00:00","resourceClassificationName":"Prognosis","references":[{"referenceId":1802,"authors":"DiMauro S, Michio H","articleTitle":"Mitochondrial DNA Deletion Syndromes","bookWebsiteJournalTitle":"GeneReviews","date":"May 3, 2011","volume":"","pages":"","url":"https://www.ncbi.nlm.nih.gov/books/NBK1203/","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":1806,"authors":"Auré K, Ogier de Baulny H, Laforet P, Jardel C, Eymard B, Lombes A","articleTitle":"Chronic progressive ophthalmoplegia with large-scale mtDNA rearrangement: can we predict progression?","bookWebsiteJournalTitle":"Brain","date":"April 17, 2007","volume":"130(6)","pages":"1516-1524","url":"http://brain.oxfordjournals.org/cgi/content/full/130/6/1516?ck=nck","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":6261,"authors":"","articleTitle":"Progressive external ophthalmoplegia","bookWebsiteJournalTitle":"Genetics Home Reference","date":"May 2016","volume":"","pages":"","url":"http://ghr.nlm.nih.gov/condition/progressive-external-ophthalmoplegia","authors2":"","placeOfPublication":"","publisher":""}]}]}],"news":[{"newsId":671,"dateCreated":"2020-05-20T13:39:00","publishDate":"2020-05-22T00:00:00","title":"NIH-Supported Research Survey to Examine Impact of COVID-19 on Rare Diseases Community","description":"The NIH-funded Rare Diseases Clinical Research Network (RDCRN) has launched an <a href=\"https://www.rarediseasesnetwork.org/COVIDsurvey \" target=\"_blank\">online research survey</a> to find out how the COVID-19 pandemic is impacting individuals with rare diseases, their families and their caregivers. Your participation can help the rare disease research community shed light on the needs of people with rare diseases during this and other potential health crises, in addition to informing future research efforts. The survey must be completed by December 15, 2020.","url":"https://www.rarediseasesnetwork.org/COVIDsurvey","lastModified":"2020-11-30T14:44:00","isFeatured":false}],"conferences":[],"phenoTypes":[],"medicalProducts":[],"EncodedName":"Chronic_progressive_external_ophthalmoplegia"}